Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
buprenorphine/naloxone, Zubsolv (OX219)
Also known as: formerly PKX219
print preview
bookmark
share with colleague
General Information
Company
Orexo AB
Description
Sublingual tablet formulation of buprenorphine and naloxone
Molecular Target
Mechanism of Action
Latest Stage of Development
Registration
Indication
Addiction
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information